New insights in the targets of action of dimethyl fumarate in endothelial cells: effects on energetic metabolism and serine synthesis in vitro and in vivo.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
25 10 2023
Historique:
received: 24 04 2022
accepted: 11 10 2023
medline: 27 10 2023
pubmed: 26 10 2023
entrez: 25 10 2023
Statut: epublish

Résumé

Dimethyl fumarate is an ester from the Krebs cycle intermediate fumarate. This drug is approved and currently used for the treatment of psoriasis and multiple sclerosis, and its anti-angiogenic activity was reported some years ago. Due to the current clinical relevance of this compound and the recently manifested importance of endothelial cell metabolism on the angiogenic switch, we wanted to elucidate whether dimethyl fumarate has an effect on energetic metabolism of endothelial cells. Different experimental approximations were performed in endothelial cells, including proteomics, isotope tracing and metabolomics experimental approaches, in this work we studied the possible role of dimethyl fumarate in endothelial cell energetic metabolism. We demonstrate for the first time that dimethyl fumarate promotes glycolysis and diminishes cell respiration in endothelial cells, which could be a consequence of a down-regulation of serine and glycine synthesis through inhibition of PHGDH activity in these cells. Dimethyl fumarate alters the energetic metabolism of endothelial cells in vitro and in vivo through an unknown mechanism, which could be the cause or the consequence of its pharmacological activity. This new discovery on the targets of this compound could open a new field of study regarding the mechanism of action of dimethyl fumarate.

Identifiants

pubmed: 37880317
doi: 10.1038/s42003-023-05443-4
pii: 10.1038/s42003-023-05443-4
pmc: PMC10600195
doi:

Substances chimiques

Dimethyl Fumarate FO2303MNI2
Fumarates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1084

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States

Informations de copyright

© 2023. Springer Nature Limited.

Références

Mol Syst Biol. 2011 Aug 16;7:523
pubmed: 21847114
J Biol Chem. 2007 Feb 16;282(7):4524-4532
pubmed: 17182618
Pharmacol Res. 2015 Sep;99:296-307
pubmed: 26188148
Cell Metab. 2018 Oct 2;28(4):573-587.e13
pubmed: 30017355
J Mass Spectrom. 2005 Oct;40(10):1309-18
pubmed: 16177962
Cell Mol Life Sci. 2006 Dec;63(24):3083-9
pubmed: 17131052
Angiogenesis. 2021 May;24(2):311-326
pubmed: 34061284
J Invest Dermatol. 2011 Jun;131(6):1347-55
pubmed: 21289642
Nature. 2011 Aug 18;476(7360):346-50
pubmed: 21760589
Nat Commun. 2021 Sep 30;12(1):5736
pubmed: 34593792
Cell. 2017 Oct 5;171(2):358-371.e9
pubmed: 28985563
Biomolecules. 2019 Aug 01;9(8):
pubmed: 31374952
Front Pharmacol. 2021 Feb 22;12:617714
pubmed: 33692690
J Biol Chem. 2015 Jan 2;290(1):457-66
pubmed: 25404730
EMBO Mol Med. 2014 Jul 25;6(9):1105-20
pubmed: 25063693
Blood. 2021 Sep 9;138(10):871-884
pubmed: 33876201
Hepatology. 2017 Aug;66(2):631-645
pubmed: 28387968
Sci Rep. 2017 Nov 7;7(1):14749
pubmed: 29116138
J Biol Chem. 1979 Apr 25;254(8):2669-76
pubmed: 429309
Nat Biotechnol. 2014 Mar;32(3):223-6
pubmed: 24727771
Cell. 2013 Aug 1;154(3):651-63
pubmed: 23911327
Med Res Rev. 2019 Jan;39(1):70-113
pubmed: 29785785
J Neurosci. 2016 Jun 8;36(23):6332-51
pubmed: 27277809
J Invest Dermatol. 2011 Jun;131(6):1356-64
pubmed: 21430706
Cell. 2015 Jul 30;162(3):540-51
pubmed: 26232224
Ther Adv Chronic Dis. 2016 Jul;7(4):198-207
pubmed: 27433310
Circ Res. 2020 Jul 3;127(2):310-329
pubmed: 32833569
Nucleic Acids Res. 2016 Jul 8;44(W1):W147-53
pubmed: 27190236
J Med Chem. 2017 Feb 23;60(4):1227-1237
pubmed: 27959531
J Biochem Biophys Methods. 2005 Sep 30;64(3):207-15
pubmed: 16182371
Cell. 2017 Oct 19;171(3):696-709.e23
pubmed: 28965760
Pharmaceutics. 2022 Dec 06;14(12):
pubmed: 36559226
Cell Metab. 2023 Mar 7;35(3):517-534.e8
pubmed: 36804058
Nat Genet. 2017 Apr;49(4):559-567
pubmed: 28250457
J Invest Dermatol. 2011 Jun;131(6):1189-91
pubmed: 21566578
J Cell Biol. 1988 Oct;107(4):1589-98
pubmed: 3049626
Med Res Rev. 2019 Sep;39(5):1923-1952
pubmed: 30756407
Nat Commun. 2018 Jun 12;9(1):2292
pubmed: 29895827
Science. 2018 Apr 27;360(6387):449-453
pubmed: 29599194
J Eur Acad Dermatol Venereol. 2018 Oct;32 Suppl 3:3-14
pubmed: 30238510
Cell Physiol Biochem. 2009;24(5-6):483-92
pubmed: 19910688

Auteurs

Mª Carmen Ocaña (MC)

Universidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, E-29071, Málaga, Spain.
IBIMA Plataforma BIONAND (Biomedical Research Institute of Málaga and nano medicine Platform), E-29590, Málaga, Spain.

Manuel Bernal (M)

Universidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, E-29071, Málaga, Spain.
IBIMA Plataforma BIONAND (Biomedical Research Institute of Málaga and nano medicine Platform), E-29590, Málaga, Spain.

Chendong Yang (C)

Children's Medical Center Research Institute, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

Carlos Caro (C)

IBIMA Plataforma BIONAND (Biomedical Research Institute of Málaga and nano medicine Platform), E-29590, Málaga, Spain.
Biomedical Magnetic Resonance Laboratory-BMRL, Andalusian Public Foundation Progress and Health-FPS, Seville, Spain.

Alejandro Domínguez (A)

IBIMA Plataforma BIONAND (Biomedical Research Institute of Málaga and nano medicine Platform), E-29590, Málaga, Spain.

Hieu S Vu (HS)

Children's Medical Center Research Institute, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

Casimiro Cárdenas (C)

Universidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, E-29071, Málaga, Spain.
Research Support Central Services (SCAI) of the University of Málaga, Málaga, Spain.

María Luisa García-Martín (ML)

IBIMA Plataforma BIONAND (Biomedical Research Institute of Málaga and nano medicine Platform), E-29590, Málaga, Spain.
Biomedical Magnetic Resonance Laboratory-BMRL, Andalusian Public Foundation Progress and Health-FPS, Seville, Spain.
Biomedical Research Networking Center in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN), 28029, Madrid, Spain.

Ralph J DeBerardinis (RJ)

Children's Medical Center Research Institute, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Eugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Howard Hughes Medical Institute, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.

Ana R Quesada (AR)

Universidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, E-29071, Málaga, Spain.
IBIMA Plataforma BIONAND (Biomedical Research Institute of Málaga and nano medicine Platform), E-29590, Málaga, Spain.
CIBER de Enfermedades Raras (CIBERER), Madrid, Spain.

Beatriz Martínez-Poveda (B)

Universidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, E-29071, Málaga, Spain. bmpoveda@uma.es.
IBIMA Plataforma BIONAND (Biomedical Research Institute of Málaga and nano medicine Platform), E-29590, Málaga, Spain. bmpoveda@uma.es.
CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. bmpoveda@uma.es.

Miguel Ángel Medina (MÁ)

Universidad de Málaga, Andalucía Tech, Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, E-29071, Málaga, Spain. medina@uma.es.
IBIMA Plataforma BIONAND (Biomedical Research Institute of Málaga and nano medicine Platform), E-29590, Málaga, Spain. medina@uma.es.
CIBER de Enfermedades Raras (CIBERER), Madrid, Spain. medina@uma.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH